861 Development of FPA157, an anti-CCR8 depleting antibody engineered to preferentially eliminate tumor-infiltrating T regulatory cells
Main Authors: | Andrew Rankin, Edwina Naik |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Similar Items
-
Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
by: Bart Neyns, et al.
Published: (2021-02-01) -
711 HBM1022, a novel anti-CCR8 antibody depletes tumor-infiltrating regulatory T cells via enhanced ADCC activity, mediates potent anti-tumor activity with Keytruda
by: Yun He, et al.
Published: (2020-11-01) -
Decreto número 861
by: Ciencia y Sociedad CyS
Published: (1983-12-01) -
FPA and globalization theories : the case of Israel
by: Aran, Amnon
Published: (2007) -
FPA evaluation of digital projects using IFPUG Method
by: Mikhail Evgenievich Kosov, et al.
Published: (2020-12-01)